NCT05498428 2026-04-13
PALOMA-2
Janssen Research & Development, LLC
Phase 2 Recruiting
Clinical Trials
7 trialsNCT06120140 2026-04-13
COCOON
Janssen Research & Development, LLC
Phase 2 Recruiting
NCT06667076 2026-04-13
COPERNICUS
Janssen Research & Development, LLC
Phase 2 Recruiting
NCT06106802 2026-02-23
Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
Samsung Medical Center
Phase 2 Recruiting
NCT06268210 2026-02-09
NeoLazer
Yonsei University
Phase 2 Recruiting
NCT05541822 2025-05-22
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
Abion Inc
Phase 2 Recruiting
NCT06156527 2023-12-05
A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker
National Cancer Center, Korea
Phase 2 Recruiting